|
Delayed
OTC Markets
16:40:30 20/08/2026 BST
|
5-day change | 1st Jan Change | ||
| 0.000100 USD | +25.00% |
|
0.00% | - |
| 3 months | +25.00% |
| 3 years | 0 |  | 0 |
| 5 years | 0 | | 0 |
| 10 years | 0 | | 0.1 |
| Manager | Title | Age | Since |
|---|---|---|---|
Michael Cohen
CEO | Chief Executive Officer | 60 | - |
| Director of Finance/CFO | 78 | 01/08/2012 | |
Steven Byle
CTO | Chief Tech/Sci/R&D Officer | 58 | 30/04/2009 |
| Director | Title | Age | Since |
|---|---|---|---|
Michael Cohen
CHM | Chairman | 60 | 19/01/2010 |
Steven Byle
BRD | Director/Board Member | 58 | 08/11/2009 |
Roger Fidler
BRD | Director/Board Member | 75 | 29/12/2009 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +25.00% | 0.00% | - | - | 0 | |
| -0.44% | -2.01% | +38.01% | -2.51% | 81.36B | |
| -5.16% | +8.34% | +475.46% | +26.89% | 59.75B | |
| +0.84% | +4.44% | -19.19% | -35.11% | 59.19B | |
| +0.76% | +3.53% | +0.08% | +36.18% | 53.33B | |
| -0.23% | +1.15% | +9.54% | +168.19% | 49.09B | |
| -1.26% | +1.65% | +59.79% | -17.79% | 32.66B | |
| -1.40% | -0.66% | +48.97% | +94.95% | 25.97B | |
| -2.00% | +6.32% | +18.24% | +209.64% | 24.39B | |
| +0.39% | -0.09% | +60.64% | +122.16% | 16.91B | |
| Average | +1.60% | +0.14% | +76.84% | +66.96% | 40.26B | |
| Weighted average by Cap. | -1.05% | -1.01% | +88.25% | +46.13% |
Employees
-
Sector
Pharmaceuticals
| Date | Price | Change |
|---|
- Stock Market
- Stocks
- PROT Stock
Select your edition
All financial news and data tailored to specific country editions
